The environment and autoimmune thyroid diseases.
暂无分享,去创建一个
[1] B. Wenzel,et al. Bacterial virulence antigens and the pathogenesis of autoimmune thyroid diseases (AITD) , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[2] W. Wiersinga. Environmental factors in autoimmune thyroid disease. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[3] K. Badenhoop. Intrathyroidal microchimerism in Graves' disease or Hashimoto's thyroiditis: regulation of tolerance or alloimmunity by fetal-maternal immune interactions? , 2004, European journal of endocrinology.
[4] T. Evans,et al. Thyroid disease. , 2003, Primary care.
[5] D. Petitti. Combination Estrogen–Progestin Oral Contraceptives , 2003 .
[6] R. Pedotti,et al. Involvement of both 'allergic' and 'autoimmune' mechanisms in EAE, MS and other autoimmune diseases. , 2003, Trends in immunology.
[7] W. Wiersinga,et al. Risk factors for and prevalence of thyroid disorders in a cross‐sectional study among healthy female relatives of patients with autoimmune thyroid disease , 2003, Clinical endocrinology.
[8] A Graham Pockley,et al. Heat shock proteins as regulators of the immune response , 2003, The Lancet.
[9] K. Beagley,et al. Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone. , 2003, FEMS immunology and medical microbiology.
[10] R. Hohlfeld,et al. Molecular mimicry in multiple sclerosis. , 2003, The New England journal of medicine.
[11] S. Gough,et al. The genetics of autoimmune endocrine disease , 2003, Clinical endocrinology.
[12] M. Widdowson,et al. Laboratory surveillance of bacterial gastroenteric pathogens in The Netherlands, 1991–2001 , 2003, Epidemiology and Infection.
[13] R. Hoermann,et al. Impact of smoking on the response to treatment of thyroid associated ophthalmopathy , 2003, The British journal of ophthalmology.
[14] P. Laurberg,et al. Interferon-alpha and autoimmune thyroid disease. , 2003, Thyroid : official journal of the American Thyroid Association.
[15] D. Middleton,et al. Enteric illness in Ontario, Canada, from 1997 to 2001. , 2003, Journal of food protection.
[16] Submitting articles to the BMJ , 2003, BMJ : British Medical Journal.
[17] W. Wiersinga,et al. Increased prevalence of antibodies to enteropathogenic Yersinia enterocolitica virulence proteins in relatives of patients with autoimmune thyroid disease , 2003, Clinical and experimental immunology.
[18] M. Gething,et al. Association of stress proteins with autoantigens: a possible mechanism for triggering autoimmunity? , 2003, Clinical and experimental immunology.
[19] A. Miyauchi,et al. The relationship of psychological factors to the prognosis of hyperthyroidism in antithyroid drug‐treated patients with Graves’ disease , 2003, Clinical endocrinology.
[20] A. Hämäläinen,et al. Enterovirus infections as a risk factor for type I diabetes: virus analyses in a dietary intervention trial , 2003, Clinical and experimental immunology.
[21] C. Eheman,et al. Autoimmune thyroid disease associated with environmental thyroidal irradiation. , 2003, Thyroid : official journal of the American Thyroid Association.
[22] L. Duntas,et al. Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. , 2003, European journal of endocrinology.
[23] K. Khosrotehrani,et al. Fetal cell microchimerism: helpful or harmful to the parous woman? , 2003, Current opinion in obstetrics & gynecology.
[24] M. Rottem. Chronic urticaria and autoimmune thyroid disease: is there a link? , 2003, Autoimmunity reviews.
[25] J. Arnaud,et al. Association of selenium with thyroid volume and echostructure in 35- to 60-year-old French adults. , 2003, European journal of endocrinology.
[26] B. Maras,et al. 123I-Interleukin-2: biochemical characterization and in vivo use for imaging autoimmune diseases , 2003 .
[27] S. Evans. Commentary: Matched cohorts can be useful. , 2003, BMJ.
[28] T. Jørgensen,et al. Thyroid peroxidase and thyroglobulin autoantibodies in a large survey of populations with mild and moderate iodine deficiency , 2003, Clinical endocrinology.
[29] Å. Lernmark,et al. Animal models of endocrine/organ-specific autoimmune diseases: do they really help us to understand human autoimmunity? , 2002, Springer Seminars in Immunopathology.
[30] G. Eisenbarth,et al. Genetics and environmental factors in endocrine/organ-specific autoimmunity: have there been any major advances? , 2002, Springer Seminars in Immunopathology.
[31] S. Pearce,et al. The genetics of autoimmune thyroid disease. , 2002, The Journal of clinical endocrinology and metabolism.
[32] A. Madec,et al. Reduction of the risk of relapse after withdrawal of medical therapy for Graves' disease. , 2002, Thyroid : official journal of the American Thyroid Association.
[33] F. Mandelli,et al. How long can we give interleukin-2? Clinical and immunological evaluation of AML patients after 10 or more years of IL2 administration , 2002, Leukemia.
[34] Arne Svejgaard,et al. A functional and structural basis for TCR cross-reactivity in multiple sclerosis , 2002, Nature Immunology.
[35] Josef Köhrle,et al. The impact of iron and selenium deficiencies on iodine and thyroid metabolism: biochemistry and relevance to public health. , 2002, Thyroid : official journal of the American Thyroid Association.
[36] J. Bach,et al. The effect of infections on susceptibility to autoimmune and allergic diseases. , 2002, The New England journal of medicine.
[37] P. Unger,et al. Intrathyroidal fetal microchimerism in Graves' disease. , 2002, The Journal of clinical endocrinology and metabolism.
[38] N. Kamel,et al. Relationship between thyroid autoimmunity and Yersinia enterocolitica antibodies. , 2002, Thyroid : official journal of the American Thyroid Association.
[39] T. Jørgensen,et al. Low goitre prevalence among users of oral contraceptives in a population sample of 3712 women , 2002, Clinical endocrinology.
[40] G. Chrousos,et al. Stress Hormones, Proinflammatory and Antiinflammatory Cytokines, and Autoimmunity , 2002, Annals of the New York Academy of Sciences.
[41] C. Osmond,et al. Is birthweight associated with thyroid autoimmunity? A study in twins. , 2002, Thyroid : official journal of the American Thyroid Association.
[42] Johannes W. Dietrich,et al. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. , 2002, The Journal of clinical endocrinology and metabolism.
[43] P. Vestergaard. Smoking and thyroid disorders--a meta-analysis. , 2002, European journal of endocrinology.
[44] M. Prummel,et al. Smoking and disease severity are independent determinants of serum adhesion molecule levels in Graves’ ophthalmopathy , 2002, Clinical and experimental immunology.
[45] S. Drača. Is Pregnancy a Model How We Should Control Some Autoimmune Diseases? , 2002, Autoimmunity.
[46] O. Bruno,et al. Development of Graves' hyperthyroidism after radioiodine treatment for a toxic nodule: is the hyperthyroidism always triggered by 1311 therapy? , 2001, Thyroid : official journal of the American Thyroid Association.
[47] Clive Osmond,et al. Effects of prenatal exposure to the Dutch famine on adult disease in later life: an overview , 2001, Molecular and Cellular Endocrinology.
[48] A. Weetman. Determinants of autoimmune thyroid disease , 2001, Nature Immunology.
[49] T. Almdal,et al. Thyroid-associated orbitopathy developed during hormone replacement therapy. , 2001, Acta ophthalmologica Scandinavica.
[50] T. Kouki,et al. Remission and recurrence of hyperthyroid Graves' disease during and after methimazole treatment when assessed by IgE and interleukin 13. , 2001, The Journal of clinical endocrinology and metabolism.
[51] B. Walker,et al. Hepatitis C virus infection. , 2001, The New England journal of medicine.
[52] C. Dayan. Stressful life events and Graves' disease revisited★ , 2001, Clinical endocrinology.
[53] U. Roggenbuck,et al. Transient stimulatory effects on pituitary-thyroid axis in patients treated with interleukin-2. , 2001, Thyroid : official journal of the American Thyroid Association.
[54] E. Nobre,et al. Relationship between the number and impact of stressful life events and the onset of Graves' disease and toxic nodular goitre★ , 2001, Clinical endocrinology.
[55] C. Goodnow. Pathways for self-tolerance and the treatment of autoimmune diseases , 2001, The Lancet.
[56] J. Parkin,et al. An overview of the immune system , 2001, The Lancet.
[57] M. Klintschar,et al. Evidence of fetal microchimerism in Hashimoto's thyroiditis. , 2001, The Journal of clinical endocrinology and metabolism.
[58] E. Sternberg,et al. Neuroendocrine regulation of autoimmune/inflammatory disease. , 2001, The Journal of endocrinology.
[59] C. Biron. Interferons α and β as Immune Regulators—A New Look , 2001 .
[60] K. Markou,et al. Iodine-Induced hypothyroidism. , 2001, Thyroid : official journal of the American Thyroid Association.
[61] H. Drexhage,et al. Iodine and thyroid autoimmune disease in animal models. , 2001, Thyroid : official journal of the American Thyroid Association.
[62] E. Roti,et al. Iodine excess and hyperthyroidism. , 2001, Thyroid : official journal of the American Thyroid Association.
[63] D. Glinoer,et al. Effects of l-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study. , 2001, European journal of endocrinology.
[64] S. Chatzipanagiotou,et al. Prevalence of Yersinia plasmid-encoded outer protein (Yop) class-specific antibodies in patients with Hashimoto's thyroiditis. , 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[65] P. Nafstad,et al. Relation between occurrence of type 1 diabetes and asthma , 2001, The Lancet.
[66] L. Hegedüs,et al. Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. , 2001, The Journal of clinical endocrinology and metabolism.
[67] T. Jørgensen,et al. Thyroid disorders in mild iodine deficiency. , 2000, Thyroid : official journal of the American Thyroid Association.
[68] J. Farrar,et al. Type I interferons and T helper development. , 2000, Immunology today.
[69] D. Green,et al. Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study. , 2000, The Journal of clinical endocrinology and metabolism.
[70] J. Ilonen,et al. Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes Prediction and Prevention Study. , 2000, Diabetes.
[71] L. Hegedüs,et al. Low birth weight is not associated with clinically overt thyroid disease: a population based twin case‐control study , 2000, Clinical endocrinology.
[72] M. Rayman,et al. The importance of selenium to human health , 2000, The Lancet.
[73] A. Like,et al. Susceptibility to diabetes is widely distributed in normal class IIu haplotype rats , 2000, Diabetologia.
[74] J. Weill,et al. Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackievirus B infection. , 2000, The Journal of infectious diseases.
[75] M. Knip,et al. Enterovirus RNA in serum is a risk factor for beta‐cell autoimmunity and clinical type 1 diabetes: A prospective study , 2000, Journal of medical virology.
[76] L. Chiovato,et al. The genetics of Hashimoto's disease. , 2000, Endocrinology and metabolism clinics of North America.
[77] C. Marcocci,et al. Management of Graves' ophthalmopathy: reality and perspectives. , 2000, Endocrine reviews.
[78] C Wilson,et al. HLA molecules, bacteria and autoimmunity. , 2000, Journal of medical microbiology.
[79] P. Galan,et al. Determinants of thyroid volume in healthy French adults participating in the SU.VI.MAX cohort , 2000, Clinical endocrinology.
[80] R. Cotter,et al. Molecular mimicry mediated by MHC class Ib molecules after infection with Gram-negative pathogens , 2000, Nature Medicine.
[81] R. Inman,et al. Molecular mimicry and autoimmunity. , 1999, The New England journal of medicine.
[82] S. Gough. The immunogenetics of Graves' disease , 1999 .
[83] C Osmond,et al. Growth in utero and during childhood among women who develop coronary heart disease: longitudinal study , 1999, BMJ.
[84] A. Compston,et al. Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis , 1999, The Lancet.
[85] G. Chrousos,et al. Stress Hormones, Th1/Th2 patterns, Pro/Anti-inflammatory Cytokines and Susceptibility to Disease , 1999, Trends in Endocrinology & Metabolism.
[86] Y. Nakamura,et al. A possible role of immunoglobulin E in patients with hyperthyroid Graves' disease. , 1999, The Journal of clinical endocrinology and metabolism.
[87] F. Trimarchi,et al. Post-Chernobyl increased prevalence of humoral thyroid autoimmunity in children and adolescents from a moderately iodine-deficient area in Russia. , 1999, Thyroid : official journal of the American Thyroid Association.
[88] T. Smith,et al. The effect of cigarette smoke constituents on the expression of HLA-DR in orbital fibroblasts derived from patients with Graves ophthalmopathy. , 1999, Ophthalmic plastic and reconstructive surgery.
[89] E. Bottone. Yersinia enterocolitica: overview and epidemiologic correlates. , 1999, Microbes and infection.
[90] M. Kazatchkine,et al. Delayed occurrence of Graves' disease after immune restoration with HAART , 1998, The Lancet.
[91] M. Nardi,et al. Cigarette Smoking and Treatment Outcomes in Graves Ophthalmopathy , 1998, Annals of Internal Medicine.
[92] Luca Chiovato,et al. Prevalence of thyroid autoantibodies in children and adolescents from Belarus exposed to the Chernobyl radioactive fallout , 1998, The Lancet.
[93] H. Lee,et al. Prevalence of human foamy virus-related sequences in the Korean population. , 1998, Journal of biomedical science.
[94] G. Bleijenberg,et al. Yersinia enterocolitica and the chronic fatigue syndrome. , 1998, The Journal of infection.
[95] P. Laurberg,et al. Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. , 1998, The Journal of clinical endocrinology and metabolism.
[96] E. Donny,et al. The effects of nicotine on the immune system , 1998, Psychoneuroendocrinology.
[97] Vanderpump,et al. The prevalence of hyperprolactinaemia and association with markers of autoimmune thyroid disease in survivors of the Whickham Survey cohort , 1998, Clinical endocrinology.
[98] P. Yeo,et al. Interferon-α Induced Thyroid Dysfunction: Three Clinical Presentations and a Review of the Literature , 1997 .
[99] M. Prummel,et al. Anti‐heat shock protein (hsp)72 antibodies are present in patients with Graves' disease (GD) and in smoking control subjects , 1997, Clinical and experimental immunology.
[100] L. Hegedüs,et al. Thyrotropin Receptor Antibodies and Graves’ Disease, a Side-Effect of 131I Treatment in Patients with Nontoxic Goiter , 1997 .
[101] F. Corstens,et al. Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goiters. , 1997, Thyroid : official journal of the American Thyroid Association.
[102] L. Hofbauer,et al. Soluble interleukin-1 receptor antagonist serum levels in smokers and nonsmokers with Graves' ophthalmopathy undergoing orbital radiotherapy. , 1997, The Journal of clinical endocrinology and metabolism.
[103] J. Klein,et al. Local Hormone Networks and Intestinal T Cell Homeostasis , 1997, Science.
[104] Fergus Shanahan,et al. A gut reaction: lymphoepithelial communication in the intestine. , 1997, Science.
[105] I. Turktas,et al. The association of chronic urticaria and angioedema with autoimmune thyroiditis , 1997, International journal of dermatology.
[106] Y. Shoenfeld,et al. Smoking and Immunity: an Additional Player in the Mosaic of Autoimmunity , 1997, Scandinavian journal of immunology.
[107] S. Benvenga. Benzodiazepine and remission of Graves' disease. , 1996, Thyroid : official journal of the American Thyroid Association.
[108] R. Ziegler,et al. Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption , 1996, Clinical endocrinology.
[109] T. Okanoue,et al. Side effects of high-dose interferon therapy for chronic hepatitis C. , 1996, Journal of hepatology.
[110] J. Peterson,et al. Yersinia enterocolitica envelope proteins that are crossreactive with the thyrotropin receptor (TSHR) also have B-cell mitogenic activity. , 1996, Journal of autoimmunity.
[111] N. Amino,et al. Onset of Graves' thyrotoxicosis after an attack of allergic rhinitis. , 1996, Thyroid : official journal of the American Thyroid Association.
[112] G. Daniels,et al. Chronic autoimmune thyroiditis. , 1996, The New England journal of medicine.
[113] J. Marinković,et al. Stressful life events in the pathogenesis of Graves' disease. , 1996, European journal of endocrinology.
[114] A. Pinchera,et al. Stressful life events and Graves' disease. , 1996, European journal of endocrinology.
[115] A. Roberts,et al. Selenium deficiency and miscarriage: a possible link? , 1996, British journal of obstetrics and gynaecology.
[116] H. Besedovsky,et al. Immune-neuro-endocrine interactions: facts and hypotheses. , 1996, Endocrine reviews.
[117] G. Weil,et al. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[118] T. Vial,et al. Immune-mediated side-effects of cytokines in humans. , 1995, Toxicology.
[119] J. French,et al. The incidence of thyroid disorders in the community: a twenty‐year follow‐up of the Whickham Survey , 1995, Clinical endocrinology.
[120] L. Kuller,et al. Prevalence of thyroid antibodies among healthy middle-aged women. Findings from the thyroid study in healthy women. , 1995, Annals of epidemiology.
[121] M. Beck,et al. Rapid genomic evolution of a non-virulent Coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates , 1995, Nature Medicine.
[122] S. Akiba,et al. Prevalence rate of thyroid diseases among autopsy cases of the atomic bomb survivors in Hiroshima, 1951-1985. , 1995, Radiation research.
[123] A. Kung. Life events, daily stresses and coping in patients with Graves' disease , 1995, Clinical endocrinology.
[124] W. Wiersinga,et al. Two cases of amiodarone-induced thyrotoxicosis successfully treated with a short course of antithyroid drugs while amiodarone was continued. , 1994, British heart journal.
[125] S. Nagataki,et al. Thyroid diseases among atomic bomb survivors in Nagasaki. , 1994, JAMA.
[126] Sydney A. Westphai,et al. Seasonal variation in the diagnosis of Graves' disease , 1994 .
[127] G. Varigos,et al. IL‐4 production is increased in cigarette smokers , 1994, Clinical and experimental immunology.
[128] A. Weetman,et al. Stimulation of extraocular muscle fibroblasts by cytokines and hypoxia: possible role in thyroid‐associated ophthalmopathy , 1994, Clinical endocrinology.
[129] K. Kodama,et al. Autoantibodies and immunoglobulins among atomic bomb survivors. , 1993, Radiation research.
[130] Y. Iwatani,et al. Recurrence of thyrotoxicosis after attack of allergic rhinitis in patients with Graves' disease. , 1993, The Journal of clinical endocrinology and metabolism.
[131] R. D. Lloyd,et al. A cohort study of thyroid disease in relation to fallout from nuclear weapons testing. , 1993, JAMA.
[132] A. Reunanen,et al. Smoking and risk of rheumatoid arthritis. , 1993, The Journal of rheumatology.
[133] M. Prummel,et al. Smoking and Risk of Gravesʼ Disease , 1993 .
[134] G. Fava,et al. Life events in the pathogenesis of Graves' disease. A controlled study. , 1993, Acta endocrinologica.
[135] D. Barker,et al. Fetal growth and autoimmune thyroid disease. , 1993, The Quarterly journal of medicine.
[136] H. Johnsen,et al. Autoimmune hypothyroidism and granulocyte‐macrophage colony‐stimulating factor , 1993, European journal of haematology.
[137] F. Karlsson,et al. Graves' disease, endocrine ophthalmopathy and smoking. , 1993, Acta endocrinologica.
[138] C. Bengtsson,et al. Smoking — A risk factor for hypothyroidism , 1993, Journal of endocrinological investigation.
[139] Y. Tomer,et al. Infection, thyroid disease, and autoimmunity. , 1993, Endocrine reviews.
[140] A. Howell,et al. Risk of thyroid dysfunction during treatment with G-CSF , 1992, The Lancet.
[141] E. Rosen,et al. Immunoreactivity to Yersinia enterocolitica antigens in patients with autoimmune thyroid disease. , 1992, The Journal of clinical endocrinology and metabolism.
[142] M. Prummel,et al. Soluble IL‐2 receptor levels in patients with Graves’ophthalmopathy , 1992, Clinical and experimental immunology.
[143] Marlsol Tellez,et al. Graves’ ophthalmopathy in relation to cigarette smoking and ethnic origin , 1992, Clinical endocrinology.
[144] S. Wallenstein,et al. A prospective study of lymphocyte-initiated immunosuppression in normal pregnancy: evidence of a T-cell etiology for postpartum thyroid dysfunction. , 1992, The Journal of clinical endocrinology and metabolism.
[145] J. Woodward,et al. Yersinia enterocolitica produces superantigenic activity. , 1992, Journal of immunology.
[146] W. Wiersinga,et al. Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. , 1991, The American journal of medicine.
[147] H. Drexhage,et al. Reversible thyroid dysfunction during treatment with GM-CSF , 1991, The Lancet.
[148] S. Hancock,et al. Thyroid diseases after treatment of Hodgkin's disease. , 1991, The New England journal of medicine.
[149] F. Martinez,et al. Increased serum IgE and increased prevalence of eosinophilia in 9-year-old children of smoking parents. , 1990, The Journal of allergy and clinical immunology.
[150] S. Gortmaker,et al. Maternal smoking and childhood asthma. , 1990, Pediatrics.
[151] B. Butland,et al. THE INFLUENCE OF PREGNANCY AND REPRODUCTIVE SPAN ON THE OCCURRENCE OF AUTOIMMUNE THYROIDITIS , 1990, Clinical endocrinology.
[152] C. Marcocci,et al. More on smoking habits and Graves’ ophthalmopathy , 1989, Journal of endocrinological investigation.
[153] A. Leznoff,et al. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. , 1989, The Journal of allergy and clinical immunology.
[154] S. Borriello,et al. Thyrotrophin (TSH)-binding proteins in bacteria and their cross-reaction with autoantibodies against the human TSH receptor. , 1989, The Journal of endocrinology.
[155] N. Amino,et al. Incidences of antibodies to Yersinia enterocolitica: high incidence of serotype O5 in autoimmune thyroid diseases in Japan. , 1989, Endocrinologia japonica.
[156] W. McKenna,et al. Amiodarone and thyroid autoimmunity in the United Kingdom. , 1988, BMJ.
[157] M. Atkins,et al. Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells. , 1988, The New England journal of medicine.
[158] A. Weetman,et al. Graves' disease , 1988 .
[159] M. Nelson,et al. IODINE IN MILK AND THE INCIDENCE OF THYROTOXICOSIS IN ENGLAND , 1988, Clinical endocrinology.
[160] K. Asplund,et al. Is endocrine ophthalmopathy related to smoking? , 1987, British medical journal.
[161] S. Nagataki,et al. Serum TSH, thyroglobulin, and thyroidal disorders in atomic bomb survivors exposed in youth: 30-year follow-up study. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[162] T. Tötterman,et al. Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon. , 1986, The Journal of clinical endocrinology and metabolism.
[163] L. Harrison,et al. Thyrotrophin (TSH) binding sites on Yersinia enterocolitica recognized by immunoglobulins from humans with Graves' disease. , 1986, Clinical and experimental immunology.
[164] M. L. Santos,et al. Antithyroid antibodies as an early marker for thyroid disease induced by amiodarone. , 1986, British medical journal.
[165] K. Pettingale,et al. RECOMBINANT GAMMA INTERFERON AND AUTOIMMUNE THYROID DISEASE , 1985, The Lancet.
[166] D. Barker,et al. Seasonality of thyrotoxicosis. , 1985, Journal of epidemiology and community health.
[167] D. Jacobson,et al. Graves' disease with ophthalmopathy following radiotherapy for Hodgkin's disease. , 1984, The American journal of the medical sciences.
[168] W. Wiersinga,et al. ASSOCIATION BETWEEN AUTOIMMUNE THYROID DISEASE, ATOPY, AND URTICARIA? , 1984, The Lancet.
[169] D. Kasper,et al. Demonstration of a saturable binding site for thyrotropin in Yersinia enterocolitica. , 1983, Science.
[170] L. Braverman,et al. Ophthalmopathy after neck irradiation therapy for Hodgkin's disease. , 1979, Cancer treatment reports.
[171] K. Chung,et al. AMIODARONE AND THE THYROID , 1979, The Lancet.
[172] C. Kay,et al. Incidence of thyroid disease associated with oral contraceptives. , 1978, British medical journal.
[173] O. Clemmensen,et al. Cell‐Mediated Immunity to Yersinia enterocolitica Serotype 3 in Patients with Thyroid Diseases , 1978, Allergy.
[174] E. Bottone,et al. Antibodies to Yersinia enterocolitica in thyroid disease. , 1976, Annals of internal medicine.
[175] D. Hadden,et al. Environmental stress and thyrotoxicosis. Absence of association. , 1974, Lancet.
[176] R. Wasnich,et al. Graves' ophthalmopathy following external neck irradiation for nonthyroidal neoplastic disease. , 1973, The Journal of clinical endocrinology and metabolism.
[177] M Winick,et al. Cellular response in rats during malnutrition at various ages. , 1966, The Journal of nutrition.
[178] H. S. Davis,et al. A Controlled Study , 1966 .
[179] B. P,et al. ANTIBODIES TO PLASMID-ENCODED PROTEINS OF ENTEROPATHOGENIC YERSINIA IN PATIENTS WITH AUTOIMMUNE THYROID DISEASE , 2003 .
[180] D. Petitti. Clinical practice. Combination estrogen-progestin oral contraceptives. , 2003, The New England journal of medicine.
[181] B. Maras,et al. 123I-Interleukin-2: biochemical characterization and in vivo use for imaging autoimmune diseases. , 2003, Nuclear medicine communications.
[182] A. Weetman. Autoimmune thyroid disease: propagation and progression. , 2003, European journal of endocrinology.
[183] H. C. Hoeck,et al. Smoking as a risk factor for Graves' disease, toxic nodular goiter, and autoimmune hypothyroidism. , 2002, Thyroid : official journal of the American Thyroid Association.
[184] P. Unger,et al. Intrathyroidal fetal microchimerism in pregnancy and postpartum. , 2002, Endocrinology.
[185] C. Biron. Interferons alpha and beta as immune regulators--a new look. , 2001, Immunity.
[186] G. Daniels. Amiodarone-induced thyrotoxicosis. , 2001, The Journal of clinical endocrinology and metabolism.
[187] J. Soule,et al. Graves' disease after 131I therapy for toxic nodule. , 2001, Thyroid : official journal of the American Thyroid Association.
[188] B. Diamond,et al. Autoimmune diseases , 2000, Bone Marrow Transplantation.
[189] N. Paunković,et al. The significant increase in incidence of Graves' disease in eastern Serbia during the civil war in the former Yugoslavia (1992 to 1995). , 1998, Thyroid : official journal of the American Thyroid Association.
[190] P. Yeo,et al. Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature. , 1997, Thyroid : official journal of the American Thyroid Association.
[191] B. Boehm,et al. Immunogenetics of Graves’ Disease , 1997 .
[192] G. Fattovich,et al. A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon. , 1996, Journal of hepatology.
[193] C. Pellegrino,et al. Anti 70 kDa heat shock protein antibodies in sera of patients affected by autoimmune and non-autoimmune thyroid diseases. , 1995, Endocrine research.
[194] C. Chen,et al. Influence of smoking on Graves' disease with or without ophthalmopathy and nontoxic nodular goiter in Taiwan. , 1994, Journal of the Formosan Medical Association = Taiwan yi zhi.
[195] E. Resetkova,et al. Seroreactivity to bacterial antigens is not a unique phenomenon in patients with autoimmune thyroid diseases in Canada. , 1994, Thyroid : official journal of the American Thyroid Association.
[196] S. Westphal. Seasonal variation in the diagnosis of Graves' disease. , 1994, Clinical endocrinology.
[197] A. Toivanen,et al. Does Yersinia induce autoimmunity? , 1994, International archives of allergy and immunology.
[198] A. Aguzzi,et al. Possible role of human foamy virus in Graves' disease. , 1993, Intervirology.
[199] N. Bagchi,et al. The role of iodine in thyroid autoimmunity: from chickens to humans: a review. , 1992, Autoimmunity.
[200] J. Heesemann,et al. Enteropathogenic Yersinia enterocolitica and organ-specific autoimmune diseases in man. , 1991, Contributions to microbiology and immunology.
[201] L. Braverman. Iodine induced thyroid disease. , 1990, Acta medica Austriaca.
[202] J. Heesemann,et al. Autoimmune thyroid diseases and enteropathogenic Yersinia enterocolitica. , 1990, Autoimmunity.
[203] N. Farid,et al. Association between Graves' ophthalmopathy and smoking. , 1990, Lancet.
[204] P. Houtman,et al. Yersinia in intestinal biopsy specimens from patients with seronegative spondyloarthropathy: correlation with specific serum IgA antibodies. , 1989, The Journal of infectious diseases.
[205] J. Garber,et al. The development of Graves' disease following radiation therapy in Hodgkin's disease. , 1988, International journal of radiation oncology, biology, physics.
[206] R Volpé,et al. Autoimmune thyroid disease. , 1984, Hospital practice.
[207] P. Skillern. Genetics of Graves' disease. , 1972, Mayo Clinic proceedings.